Literature DB >> 15731055

A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.

Jose Rey-Ladino1, Kasra M Koochesfahani, Michelle L Zaharik, Caixia Shen, Robert C Brunham.   

Abstract

The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia-specific CD4+ T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia-specific CD4+ T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis. The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731055      PMCID: PMC1064943          DOI: 10.1128/IAI.73.3.1568-1577.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  The potential for vaccine development against chlamydial infection and disease.

Authors:  R C Brunham; D J Zhang; X Yang; G M McClarty
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

2.  Functional subsets of memory T cells identified by CCR7 expression.

Authors:  F Sallusto; A Langenkamp; J Geginat; A Lanzavecchia
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

Review 3.  Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity.

Authors:  Y J Liu
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

4.  Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells.

Authors:  S Prebeck; C Kirschning; S Dürr; C da Costa; B Donath; K Brand; V Redecke; H Wagner; T Miethke
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

5.  Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy.

Authors:  J H Shaw; V R Grund; L Durling; H D Caldwell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.

Authors:  H Lu; X Yang; K Takeda; D Zhang; Y Fan; M Luo; C Shen; S Wang; S Akira; R C Brunham
Journal:  Mol Med       Date:  2000-07       Impact factor: 6.354

7.  Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Authors:  S G Morrison; H Su; H D Caldwell; R P Morrison
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development.

Authors:  J U Igietseme; G A Ananaba; J Bolier; S Bowers; T Moore; T Belay; F O Eko; D Lyn; C M Black
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

9.  Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection.

Authors:  X Yang; R C Brunham
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

10.  Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.

Authors:  M V Dhodapkar; R M Steinman; J Krasovsky; C Munz; N Bhardwaj
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

View more
  20 in total

1.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

2.  Plasmacytoid dendritic cells modulate nonprotective T-cell responses to genital infection by Chlamydia muridarum.

Authors:  Raymond J Moniz; Ann M Chan; Lynn K Gordon; Jonathan Braun; Moshe Arditi; Kathleen A Kelly
Journal:  FEMS Immunol Med Microbiol       Date:  2010-01-19

Review 3.  Chemokine-mediated immune responses in the female genital tract mucosa.

Authors:  Maud Deruaz; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

Review 4.  Development of a Chlamydia trachomatis T cell Vaccine.

Authors:  Karuna P Karunakaran; Hong Yu; Leonard J Foster; Robert C Brunham
Journal:  Hum Vaccin       Date:  2010-08-01

Review 5.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

6.  Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.

Authors:  Hong Yu; Karuna P Karunakaran; Isabelle Kelly; Caixia Shen; Xiaozhou Jiang; Leonard J Foster; Robert C Brunham
Journal:  J Immunol       Date:  2011-02-04       Impact factor: 5.422

Review 7.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

8.  Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles.

Authors:  Michelle L Zaharik; Tarun Nayar; Rick White; Caixia Ma; Bruce A Vallance; Nadine Straka; Xiaozhou Jiang; Jose Rey-Ladino; Caixia Shen; Robert C Brunham
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

9.  Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity.

Authors:  Xiaozhou Jiang; Caixia Shen; Jose Rey-Ladino; Hong Yu; Robert C Brunham
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

10.  Prostaglandin E2 modulates dendritic cell function during chlamydial genital infection.

Authors:  Wei Liu; Kathleen Ann Kelly
Journal:  Immunology       Date:  2007-08-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.